INNOVATE Q3 revenue $242.2M (-35.5% YoY); net loss $15.3M vs $7.3M loss YoY

INNOVATE Corp.

2024-Q3 EPS reported -$1.69 revenue$870,500,000

DBM Global revenue $232.8M (-37% YoY); gross margins expanded 360 bps to 18.8%
R2 record worldwide system unit sales growth of 416% YoY; $3.0M Life Sciences revenue
Spectrum revenue $6.4M (+$1M YoY); Adjusted EBITDA turned positive to $1.7M
Consolidated Adjusted EBITDA $16.8M (-24% YoY); cash $51.0M vs $80.8M Dec 2023
Reverse stock split 1-for-10 effected Aug 8, 2024; EPS retroactively adjusted

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.